Início › Sobrepeso › Arizona

Ensaios clínicos de Sobrepeso em Arizona

29 estudos para Sobrepeso estão buscando participantes em locais em Arizona.

Cidades em Arizona

Texto oficial do estudo (Inglês)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Headlands Research - Scottsdale /ID# 282571, Scottsdale

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

AMR Clinical, Tempe

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Care Access - 801 South Power Road, Mesa, Mesa
Absolute Clinical Research, Phoenix
Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

University of Arizona, Tucson

RecrutandoFase 3

Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Headlands Research - Scottsdale, Scottsdale

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Synexus Clinical Research US, Inc., Phoenix
Medical Advancement Centers of Arizona, Phoenix

RecrutandoFase 3

Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RIO Clinical Trials - Phoenix, Phoenix
Headlands Research - Scottsdale, Scottsdale
Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Care Access - 801 South Power Road, Mesa, Mesa
Elite Pain and Spine Institute - South Crimson Road, Mesa
Elite Clinical Studies, LLC, Phoenix
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Tucson Clinical Research Institute, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Mesa
Research Site, Phoenix
Research Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Phoenix
AURORA-1 Clinical Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Peoria
AURORA-2 Clinical Site, Phoenix
AURORA-2 Clinical Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Arizona Clinical Trials, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Helios Clinical Research - Phoenix, Phoenix

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Arizona Clinical Trials, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Chandler
ACCOMPLISH-2 Research Site, Phoenix
ACCOMPLISH-2 Research Site, Sun City West
e mais 1

RecrutandoFase 3Voluntários saudáveis bem-vindos

Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Dignity Health, Mercy Gilbert, Gilbert

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07571109

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
Synexus Clinical Research US, Inc., Phoenix
Pima Heart, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Medical Dermatology Specialists, Phoenix

RecrutandoFase 4

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06857942

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Sun City

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Gilbert Center for Family Medicine, Gilbert

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Phoenix
Kailera Clinical Site, Sun City

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Arizona Clinical Trials, Chandler
Epic Medical Research - Sun City, Sun City

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Mesa

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Exponent Phoenix, Phoenix

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Phoenix
ACCOMPLISH-1 Research Site, Sun City West
ACCOMPLISH-1 Research Site, Tucson

RecrutandoFase 3

Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

The University of Arizona College of Medicine- Phoenix, Phoenix

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT06499857

Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.